Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
iktos
Iktos is a company leveraging cutting-edge AI and robotics to transform drug discovery. Their integrated platform covers the entire DMTA cycle, from generative AI-driven molecular design with Makya,…
iktos
Iktos is a company leveraging cutting-edge AI and robotics to transform drug discovery. Their integrated platform covers the entire DMTA cycle, from generative AI-driven molecular design with Makya,…
TL;DR
Core offering: Generative AI and robotics platform for small-molecule drug design, retrosynthesis, and automated synthesis
Headquarters: Paris, Île-de-France, France
Founded: 2016
Notable funding: €15.5M Series A (March 2023)
Recent M&A: Acquired Synsight (July 2024) to add biology capabilities
Company Overview
Problem Domain
Small-molecule drug discovery (molecular design, synthesis planning, and synthesis automation)
Founded
2016
Industry
Biotechnology
Funding Track Record
€15.5M
Dealroom lists the round as co-led by M Ventures and Debiopharm Group
€900k
Recorded as debt financing
Investor Signal
“Investors include Omnes Capital, Debiopharm Group (Debiopharm Innovation Fund), M Ventures, and Bpifrance; earlier support from HEC Paris and Agoranov”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,500+
New This Week